Compounds > nelfinavir
Page last updated: 2024-08-24

nelfinavir and Carcinoma, Squamous Cell

nelfinavir has been researched along with Carcinoma, Squamous Cell in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (57.14)29.6817
2010's2 (28.57)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Garcia-Soto, AE; Hu, JJ; Jimenez, EA; Kossenkov, A; Lin, LL; Lucci, JA; Maity, A; McKenzie, ND; Mills, GB; Pearson, JM; Portelance, L; Qureshi, R; Schwartz, L; Simpkins, F; Whicker, ME1
Kim, JY; Lee, BM; Park, YJ; Yoon, S1
Buatti, JM; Gupta, AK; Lee, JH; Maity, A; Quon, H; Smith, G; Spitz, DR; Wilke, WW1
Asuncion, A; Berry, GJ; Chapman, CH; Dimmick, KW; Filion, EJ; Green, J; Hara, W; Loo, BW; Marko, D; Shen, J; Tran, PT; Wakelee, H1
Deutsch, E; Vozenin-Brotons, MC1
Bernhard, EJ; Cerniglia, GJ; Evans, SM; Gupta, AK; Hahn, SM; Jiang, Z; Koch, CJ; Maity, A; Pore, N1
Adachi, Y; Bandobashi, K; Ikezoe, T; Kobayashi, M; Koeffler, HP; Nishioka, C; Taguchi, H; Takeuchi, S; Takeuchi, T; Yang, Y1

Trials

1 trial(s) available for nelfinavir and Carcinoma, Squamous Cell

ArticleYear
Phase 1 trial of nelfinavir added to standard cisplatin chemotherapy with concurrent pelvic radiation for locally advanced cervical cancer.
    Cancer, 2021, 07-01, Volume: 127, Issue:13

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Female; Humans; Nelfinavir; Uterine Cervical Neoplasms

2021

Other Studies

6 other study(ies) available for nelfinavir and Carcinoma, Squamous Cell

ArticleYear
Co-treatment With HIV Protease Inhibitor Nelfinavir Greatly Increases Late-phase Apoptosis of Drug-resistant KBV20C Cancer Cells Independently of P-Glycoprotein Inhibition.
    Anticancer research, 2019, Volume: 39, Issue:7

    Topics: Antimitotic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Squamous Cell; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Fluphenazine; Furans; HIV Protease Inhibitors; Humans; Ketones; Lopinavir; Mouth Neoplasms; Nelfinavir; Ritonavir; Vincristine

2019
Radiation response in two HPV-infected head-and-neck cancer cell lines in comparison to a non-HPV-infected cell line and relationship to signaling through AKT.
    International journal of radiation oncology, biology, physics, 2009, Jul-01, Volume: 74, Issue:3

    Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Enzyme Inhibitors; ErbB Receptors; Head and Neck Neoplasms; Human papillomavirus 16; Humans; Nelfinavir; Papillomavirus Infections; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Radiation Tolerance

2009
Marked tumor response and fatal hemoptysis during radiation for lung cancer in a human immunodeficiency virus-positive patient taking nelfinavir.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2009, Volume: 4, Issue:12

    Topics: Carcinoma, Squamous Cell; Fatal Outcome; Hemoptysis; HIV Infections; HIV Protease Inhibitors; HIV Seropositivity; HIV-1; Humans; Lung Neoplasms; Male; Nelfinavir

2009
Radiosensitivity of human papillomavirus-related tumors: in regard to Gupta et al. (Int J Radiat Oncol Biol Phys 2009;74:928-933).
    International journal of radiation oncology, biology, physics, 2011, Feb-01, Volume: 79, Issue:2

    Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Enzyme Inhibitors; ErbB Receptors; Head and Neck Neoplasms; Human papillomavirus 16; Humans; Nelfinavir; Papillomavirus Infections; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Radiation Tolerance

2011
Nelfinavir down-regulates hypoxia-inducible factor 1alpha and VEGF expression and increases tumor oxygenation: implications for radiotherapy.
    Cancer research, 2006, Sep-15, Volume: 66, Issue:18

    Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Down-Regulation; Female; Head and Neck Neoplasms; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Nelfinavir; Neovascularization, Pathologic; Oxygen; Protease Inhibitors; Proto-Oncogene Proteins c-akt; Radiation Tolerance; Random Allocation; Sp1 Transcription Factor; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2006
NFV, an HIV-1 protease inhibitor, induces growth arrest, reduced Akt signalling, apoptosis and docetaxel sensitisation in NSCLC cell lines.
    British journal of cancer, 2006, Dec-18, Volume: 95, Issue:12

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Docetaxel; Down-Regulation; Drug Combinations; Glycogen Synthase Kinases; HIV Protease Inhibitors; Humans; Intracellular Signaling Peptides and Proteins; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nelfinavir; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; RNA, Small Interfering; Signal Transduction; Taxoids; Tumor Suppressor Protein p53

2006